Join our newsletter
Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update.
EpiVax devises ‘recipe’ for coronavirus vaccine – Providence Business News interview
By Elizabeth Graham -February 21, 2020 2:35 am...
EpiVax worked for 21 years to be able to make a vaccine in 24 hours!
EpiVax is dedicated to providing continuously...
Press Release: EpiVax Announces Record Year for Growth in 2019 and Sets New Milestones for 2020
Providence, R.I., December 23, 2019 – EpiVax...
Press Release: On Eve of New Decade, EpiVax Re-Pledges Commitment to Improving Health Everywhere
Providence, R.I., December 17, 2019 EpiVax, Inc....
Press release: EpiVax’s Novel Tregitope technology offers promising outcomes in the Treatment of Type 1 Diabetes
Providence, November 6th 2019 EpiVax announces...
Press Release: Chugai Renews License to EpiVax’s ISPRI In Silico Toolkit for Immunogenicity Assessment
Announced today, Chugai Pharmaceutical Co.,...
EpiVax, Turning 21, Celebrates Birthday by “Improving Human Health Everywhere”
Providence, R.I., May 28, 2019 – EpiVax, Inc. is...
EpiVax Gives Back in 2018, Looks Forward to 2019!
Making Epi-Resolutions for 2019:
In 2019, EpiVax will strive to help improve human-to-human interactions, while supporting the right of every human to speak freely, to be healthy, to build diverse communities and to wage peace. We will also promote humane practices towards animals and work to protect and honor the Earth, our home. And, of course, while we continue to create and innovate to benefit humankind, we’ll also pay it forward, volunteering and donating to not-for profits that share our core values.
Leslie J. De Groot MD, 1928-2018
Leslie J. DeGroot MD (“Les”) was born on a dairy farm in Fort Edward NY in 1928, dedicated his life to thyroid disease research and endocrinology and died soon after his 90th birthday, on October 23, 2018 in Nonquitt, Massachusetts, surrounded by his many loving grandchildren, children and his wife.
Breaking News: FDA awards $1 million to EpiVax, CUBRC, to assess generic peptide drugs
This original article was published on October...
EpiVax Opens New Headquarters and Celebrates 20 Years of Fearless Science
PROVIDENCE, R.I., June 11, 2018 — EpiVax...
$325K NIH Grant to EpiVax to Enable Development of Personalized Risk Assessment Tool for Enzyme Replacement Therapy in Pompe Disease
PROVIDENCE, R.I., May 18, 2018 /PRNewswire/ --...







